Product Pricing

September 5, 2024

All About Tesofensine

Tesofensine, A Novel Antiobesity Medicine, Silences Gabaergic Hypothalamic Neurons Pmc We discovered a considerable distinction in complete visceral fat (composed of gonadal, perirenal, and mesenteric fat) between the HFD-Saline and HFD-Tesofensine teams (Fig 1C). Nonetheless, the total fat in the...

Read more →
September 5, 2024

Pharmaceuticals Complimentary Full-text Excessive Weight Drug Update: The Shed Decade?

Weight Reduction: Leading 3 Methods To Treat Excessive Weight Rather than complying with a "one-size-fits-all" strategy, we provide each person with a customized plan to satisfy their details demands. We utilize FDA-approved medicines to regulate cravings, nutritional supplements to sustain power...

Read more →
September 5, 2024

Tesofensine, An Unique Antiobesity Drug, Silences Gabaergic Hypothalamic Nerve Cells Pmc

Can Tesofensine Treat Obesity? Unwinding The Secret Behind A New Weight Management Medicine It mediates its weight-lowering result primarily by acting on the CNS as a satiety signal to decrease food intake and by increasing energy expenditure and thermogenesis (132 ). As necessary, it was...

Read more →
September 5, 2024

Stimulants For The Control Of Hedonic Appetite

Struggling To Attain Weight Reduction Goals? Discover The Power Of Tesofensine And Glp-1 Agonists! In harmony with this, topiramate increases energy expense and lowers hunger through incongruity of alpha-amino-3-hydroxyl-4-isoxazole-propionic acid kainate (AMPA/KA) receptors [28] However, Qsymia ®...

Read more →
September 5, 2024

Weight Loss: Top 3 Means To Deal With Excessive Weight

Treatment Of Obtained Hypothalamic Weight Problems: Now And The Future FGF21 is secreted largely from the liver under conditions of fasting, and decreases body weight by enhancing energy expense by means of central and outer mechanisms310,311,312,313. It binds to the CCK1 receptor (CCK1R) to...

Read more →
Welcome to MediQuest Pharmaceuticals, where innovation meets excellence in the pharmaceutical industry. I am Michael Johnson, the founder and driving force behind MediQuest Pharmaceuticals. With over two decades of experience in drug development and pharmaceutical regulations, I have dedicated my career to advancing healthcare through innovative pharmaceutical solutions. Born and raised in the bustling city of Boston, my fascination with science began at a young age, nurtured by countless hours spent in the local library reading about chemistry and biology. This passion led me to pursue a degree in Medicinal Chemistry at the University of Massachusetts, followed by a Ph.D. in Pharmaceutical Sciences. After completing my education, I ventured into the pharmaceutical industry, where I gained extensive experience in various facets of drug development and manufacturing.